Literature DB >> 22052607

Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR.

L Selva1, P Ciruela, C Esteva, M F de Sevilla, G Codina, S Hernandez, F Moraga, J J García-García, A Planes, F Coll, I Jordan, N Cardeñosa, J Batalla, L Salleras, A Dominguez, C Muñoz-Almagro.   

Abstract

Serotype 3 is one of the most often detected pneumococcal serotypes in adults and it is associated with serious disease. In contrast, the isolation of serotype 3 by bacterial culture is unusual in children with invasive pneumococcal disease (IPD). The purpose of this study was to learn the serotype distribution of IPD, including culture-negative episodes, by using molecular methods in normal sterile samples. We studied all children<5 years of age with IPD admitted to two paediatric hospitals in Catalonia, Spain, from 2007 to 2009. A sequential real-time polymerase chain reaction (PCR) approach was added to routine methods for the detection and serotyping of pneumococcal infection. Among 257 episodes (219 pneumonia, 27 meningitis, six bacteraemia and five others), 33.5% were identified by culture and the rest, 66.5%, were detected exclusively by real-time PCR. The most common serotypes detected by culture were serotypes 1 (26.7%) and 19A (25.6%), and by real-time PCR, serotypes 1 (19.8%) and 3 (18.1%). Theoretical coverage rates by the PCV7, PCV10 and PCV13 vaccines were 10.5, 52.3 and 87.2%, respectively, for those episodes identified by culture, compared to 5.3, 31.6 and 60.2% for those identified only by real-time PCR. Multiplex real-time PCR has been shown to be useful for surveillance studies of IPD. Serotype 3 is underdiagnosed by culture and is important in paediatric IPD.

Entities:  

Mesh:

Year:  2011        PMID: 22052607     DOI: 10.1007/s10096-011-1468-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  33 in total

1.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

2.  The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.

Authors:  Deborah Lehmann; Judith Willis; Hannah C Moore; Carolien Giele; Denise Murphy; Anthony D Keil; Catherine Harrison; Kathy Bayley; Michael Watson; Peter Richmond
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

3.  Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children.

Authors:  Jeffrey M Bender; Krow Ampofo; Carrie L Byington; Matthew Grinsell; Kent Korgenski; Judy A Daly; Edward O Mason; Andrew T Pavia
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

4.  Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.

Authors:  Lotta Siira; Merja Rantala; Jari Jalava; Antti J Hakanen; Pentti Huovinen; Tarja Kaijalainen; Outi Lyytikäinen; Anni Virolainen
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

5.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

6.  Clonal structure and 21-year evolution of Streptococcus pneumoniae serotype 1 isolates in northern Spain.

Authors:  J M Marimon; M Ercibengoa; M Alonso; M Zubizarreta; E Pérez-Trallero
Journal:  Clin Microbiol Infect       Date:  2009-09       Impact factor: 8.067

7.  Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

Authors:  A Fenoll; J J Granizo; L Aguilar; M J Giménez; L Aragoneses-Fenoll; G Hanquet; J Casal; D Tarragó
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

8.  Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome.

Authors:  Simon Rückinger; Rüdiger von Kries; Annette Siedler; Mark van der Linden
Journal:  Pediatr Infect Dis J       Date:  2009-02       Impact factor: 2.129

9.  Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease.

Authors:  Matthias Imöhl; Ralf René Reinert; Christina Ocklenburg; Mark van der Linden
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

10.  Pediatric parapneumonic empyema, Spain.

Authors:  Ignacio Obando; Carmen Muñoz-Almagro; Luis A Arroyo; David Tarrago; David Sanchez-Tatay; David Moreno-Perez; Sahar S Dhillon; Cristina Esteva; Susanna Hernandez-Bou; Juan J Garcia-Garcia; William P Hausdorff; Angela B Brueggemann
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more
  12 in total

1.  Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.

Authors:  Susanna Hernández-Bou; Borja Gómez; Santiago Mintegi; Juan J García-García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-07       Impact factor: 3.267

2.  Rapid and easy identification of capsular serotypes of Streptococcus pneumoniae by use of fragment analysis by automated fluorescence-based capillary electrophoresis.

Authors:  Laura Selva; Eva del Amo; Pedro Brotons; Carmen Muñoz-Almagro
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

3.  Direct identification of Streptococcus pneumoniae capsular types in pleural fluids by using multiplex PCR combined with automated fluorescence-based capillary electrophoresis.

Authors:  Laura Selva; Christoph Berger; Juan Jose Garcia-Garcia; Hector de Paz; David Nadal; Carmen Muñoz-Almagro
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

4.  Serotypes and genotypes of invasive pneumococci in the central part of Slovenia.

Authors:  Manica Müller Premru; Bojana Beović; Marko Pokorn; Vesna Cvitković Špik
Journal:  Wien Klin Wochenschr       Date:  2015-04-01       Impact factor: 1.704

5.  Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Authors:  Pilar Ciruela; Núria Soldevila; Laura Selva; Sergi Hernández; Juan Jose Garcia-Garcia; Fernando Moraga; Mariona F de Sevilla; Gemma Codina; Ana Maria Planes; Cristina Esteva; Francis Coll; Neus Cardeñosa; Iolanda Jordan; Joan Batalla; Luis Salleras; Carmen Muñoz-Almagro; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

6.  Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.

Authors:  Juan Picazo; Jesus Ruiz-Contreras; Juan Casado-Flores; Sagrario Negreira; Maria-Jesus García-de-Miguel; Teresa Hernández-Sampelayo; Enrique Otheo; Cristina Méndez
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

7.  Estimation of the invasive disease potential of Streptococcus pneumoniae in children by the use of direct capsular typing in clinical specimens.

Authors:  E del Amo; L Selva; M F de Sevilla; P Ciruela; P Brotons; M Triviño; S Hernandez; J J Garcia-Garcia; Á Dominguez; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

8.  Serotype 3 pneumococci sequester platelet-derived human thrombospondin-1 via the adhesin and immune evasion protein Hic.

Authors:  Ulrike Binsker; Thomas P Kohler; Krystin Krauel; Sylvia Kohler; Johanna Habermeyer; Hansjörg Schwertz; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2017-02-16       Impact factor: 5.157

9.  Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain.

Authors:  Sergi Hernández; Fernando Moraga-Llop; Alvaro Díaz; Mariona F de Sevilla; Pilar Ciruela; Carmen Muñoz-Almagro; Gemma Codina; Magda Campins; Juan José García-García; Cristina Esteva; Conchita Izquierdo; Sebastià González-Peris; Johanna Martínez-Osorio; Sonia Uriona; Luis Salleras; Ángela Domínguez
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

10.  Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain.

Authors:  Eva Del Amo; Cristina Esteva; Susanna Hernandez-Bou; Carmen Galles; Marian Navarro; Goretti Sauca; Alvaro Diaz; Paula Gassiot; Carmina Marti; Nieves Larrosa; Pilar Ciruela; Mireia Jane; Raquel Sá-Leão; Carmen Muñoz-Almagro
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.